These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21327677)

  • 21. Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Mateo AJ; Mangues I; Jurjo C
    Cornea; 2006 Dec; 25(10):1220-3. PubMed ID: 17172902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical excision, cryotherapy, autolimbal transplantation and mitomycin-C in treatment of conjunctival-corneal intraepithelial neoplasia.
    Doganay S; Er H; Tasar A; Gürses I
    Int Ophthalmol; 2005; 26(1-2):53-7. PubMed ID: 16779567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical mitomycin following cryotherapy for treatment of recurrent ocular surface melanoma.
    Rudkin AK; Muecke JS
    Can J Ophthalmol; 2009 Oct; 44(5):e41. PubMed ID: 19798814
    [No Abstract]   [Full Text] [Related]  

  • 24. Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
    Papandroudis AA; Dimitrakos SA; Stangos NT
    Cornea; 2002 Oct; 21(7):715-7. PubMed ID: 12352093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA; Farid SF
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of corneal limbal dermoids: retrospective study of different techniques and use of Mitomycin C.
    Lang SJ; Böhringer D; Reinhard T
    Eye (Lond); 2014 Jul; 28(7):857-62. PubMed ID: 24858530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA
    Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH; Kim YH; Kim MS; Kim EC
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C.
    Yamamoto N; Ohmura T; Suzuki H; Shirasawa H
    Ophthalmology; 2002 Feb; 109(2):249-52. PubMed ID: 11825803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.
    Heigle TJ; Stulting RD; Palay DA
    Am J Ophthalmol; 1997 Sep; 124(3):397-9. PubMed ID: 9439368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in ultrastructure and c-met expression in a case of ocular epithelial dysplasia following topical mitomycin C treatment.
    Saika S; Miyamoto T; Kawashima Y; Jinza K; Okada Y; Yamanaka O; Ohnishi Y; Ooshima A
    Jpn J Ophthalmol; 2000; 44(6):639-42. PubMed ID: 11094180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Ramos-López JF; Martínez-Costa Pérez R; Cisneros Lanuza AL; Francés Muñoz E; Monte Boque E; Muñoz Gómez MC; López-Sánchez EV; Menezo Rozalén JL
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):375-8. PubMed ID: 15306963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined intraepithelial squamous neoplasia and atypical fibroxanthoma of the cornea and limbus.
    Engelbrecht NE; Ford JG; White WL; Yeatts RP
    Am J Ophthalmol; 2000 Jan; 129(1):94-6. PubMed ID: 10653421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent intraepithelial neoplasia treatment.
    Schechter BA; Nagler RS; Schrier A
    Ophthalmology; 2005 Jul; 112(7):1319; author reply 1319. PubMed ID: 15993243
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimetabolites in ocular surface neoplasia.
    Majmudar PA; Epstein RJ
    Curr Opin Ophthalmol; 1998 Aug; 9(4):35-9. PubMed ID: 10387466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.